Center-Authored Papers

Filters: Author is Andersen, M Robyn  [Clear All Filters]
2007
Bricker JB, Peterson AV, Sarason IG, Andersen MR, Rajan BK.  2007.  Changes in the influence of parents' and close friends' smoking on adolescent smoking transitions.. Addictive behaviors. 32(4):740-57. Abstract
Bricker JB, Andersen MR, Rajan BK, Sarason IG, Peterson AV.  2007.  The role of schoolmates' smoking and non-smoking in adolescents' smoking transitions: a longitudinal study.. Addiction (Abingdon, England). 102(10):1665-75. Abstract
Bricker JB, Peterson AV, Andersen MR, Sarason IG, Rajan BK, Leroux BG.  2007.  Parents' and older siblings' smoking during childhood: changing influences on smoking acquisition and escalation over the course of adolescence.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 9(9):915-26. Abstract
2008
Andersen MR, Bowen DJ, Morea J, Stein K, Baker F.  2008.  Frequent search for sense by long-term breast cancer survivors associated with reduced HRQOL.. Women & health. 47(4):19-37. Abstract
Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban ND.  2008.  Combining a symptoms index with CA 125 to improve detection of ovarian cancer.. Cancer. 113(3):484-9. Abstract
Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK.  2008.  Complementary and alternative medicine provider use and expenditures by cancer treatment phase.. The American journal of managed care. 14(5):326-34. Abstract
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
2009
Lowe KA, Andersen MR, Urban ND, Paley P, Drescher CW, Goff BA.  2009.  The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.. Gynecologic oncology. 114(2):225-30. Abstract
Andersen MR, Bowen DJ, Morea J, Stein KD, Baker F.  2009.  Involvement in decision-making and breast cancer survivor quality of life.. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 28(1):29-37. Abstract
Bricker JB, Rajan BK, Zalewski M, Ramey M, Peterson AV, Andersen MR.  2009.  Psychological and social risk factors in adolescent smoking transitions: a population-based longitudinal study.. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 28(4):439-47. Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
2010
Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban ND.  2010.  Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.. Gynecologic oncology. 116(3):378-83. Abstract
2011
Andersen MR.  2011.  Symptoms of breast cancer in an age of technologic screening.. Journal of women's health (2002). 20(8):1129-31.
2012
Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR.  2012.  Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.. Gynecologic oncology. 124(2):230-5. Abstract
Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA.  2012.  Involvement in decision-making about treatment and ovarian cancer survivor quality of life.. Gynecologic oncology. 124(3):465-470. Abstract
2013
Sweet ES, Standish LJ, Goff BA, Andersen MR.  2013.  Adverse Events Associated With Complementary and Alternative Use in Ovarian Cancer Patients - editorial comment. Obstetrical & Gynecological Survey. 68:741-742. Abstract
Sweet ES, Standish LJ, Goff BA, Andersen MR.  2013.  Adverse Events Associated With Complementary and Alternative Medicine Use in Ovarian Cancer Patients.. Integrative cancer therapies. Abstract
Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA.  2013.  Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer.. Journal of alternative and complementary medicine (New York, N.Y.). Abstract
2014
Andersen MR, Lowe KA, Goff BA.  2014.  Value of symptom-triggered diagnostic evaluation for ovarian cancer.. Obstetrics and gynecology. 123(1):73-9. Abstract
Andersen MR, Thorpe J, Buist DSM, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban ND.  2014.  Cancer risk awareness and concern among women with a family history of breast or ovarian cancer.. Behavioral medicine (Washington, D.C.). Abstract
Karlan BY, Thorpe JD, Watabayashi K, Drescher CW, Palomares MR, Daly M, Paley PJ, Hillard PJ, Andersen MR, Anderson GL et al..  2014.  Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2015
Andersen MR, Afdem K, Hager S, Gaul M, Sweet E, Standish LJ.  2015.  The 'cause' of my cancer, beliefs about cause among breast cancer patients and survivors who do and do not seek IO care.. Psycho-oncology. Abstract
2016
Sweet E, Dowd F, Zhou M, Standish LJ, Andersen MR.  2016.  The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy.. Evidence-based complementary and alternative medicine : eCAM. 2016:4382687. Abstract
Standish LJ, Dowd F, Sweet E, Dale L, Weaver M, Osborne B, Andersen MR.  2016.  Breast Cancer Integrative Oncology Care and Its Costs.. Integrative cancer therapies. Abstract
Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N et al..  2016.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.. Cancer. 122(22):3509-3518. Abstract